The Biosimilars Conference 2015 provides knowledge on the current status for biosimilars in EU and internationally with a focus on regulatory and scientific challenges as well as market access.
The Biosimilars Conference 2015 covers topics such as:
- International development of biosimilars
- Current regulatory status of biosimilars in the EU
- Pharmacovigilance issues related to biosimilars – EU and globally
- Naming of biologicals including biosimilars
- Market experience with biosimilars including market access and pricing Patient and physicians approach to use of biosimilars
The Biosimilars Conference 2015 brings together attendees from:
- The pharmaceutical industry and service providers including
- Pharmacovigilance staff
- Regulatory affairs personnel
- Clinical and medical personnel
- Regulatory agencies
- Physicians and their scientific societies
- Academic institutions
- Patients organisations
